Cresco Labs Inc
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes… Read more
Cresco Labs Inc (CRLBF) - Total Liabilities
Latest total liabilities as of September 2025: $940.17 Million USD
Based on the latest financial reports, Cresco Labs Inc (CRLBF) has total liabilities worth $940.17 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Cresco Labs Inc - Total Liabilities Trend (2016–2024)
This chart illustrates how Cresco Labs Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Cresco Labs Inc Competitors by Total Liabilities
The table below lists competitors of Cresco Labs Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Impact Growth REIT
BK:IMPACT
|
Thailand | ฿4.50 Billion |
|
Aeris Resources Ltd
AU:AIS
|
Australia | AU$257.43 Million |
|
Network18 Media & Investments Limited
NSE:NETWORK18
|
India | ₹38.98 Billion |
|
Taiwan Hopax Chemsistry MFG Co Ltd
TWO:6509
|
Taiwan | NT$2.24 Billion |
|
Greenwich Lifesciences Inc
NASDAQ:GLSI
|
USA | $1.62 Million |
|
Thayer Ventures Acquisition Corporation II Class A Ordinary Shares
NASDAQ:TVAI
|
USA | $8.51 Million |
|
Jiangsu Yuxing Film Tech
SHE:300305
|
China | CN¥1.38 Billion |
|
KNR Constructions Limited
NSE:KNRCON
|
India | ₹29.31 Billion |
Liability Composition Analysis (2016–2024)
This chart breaks down Cresco Labs Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.49 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.19 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.73 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Cresco Labs Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Cresco Labs Inc (2016–2024)
The table below shows the annual total liabilities of Cresco Labs Inc from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $967.18 Million | +3.95% |
| 2023-12-31 | $930.40 Million | -6.59% |
| 2022-12-31 | $996.01 Million | +1.35% |
| 2021-12-31 | $982.73 Million | +61.54% |
| 2020-12-31 | $608.37 Million | +106.98% |
| 2019-12-31 | $293.93 Million | +736.70% |
| 2018-12-31 | $35.13 Million | +3196.11% |
| 2017-12-31 | $1.07 Million | +6.89% |
| 2016-12-31 | $997.07K | -- |